F1F0-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation
F1F0-ATP synthase inhibitory factor 1 (IF1) inhibits the reverse mode of F1F0-ATP synthase, and therefore protects cellular ATP content at the expense of accelerated loss of mitochondrial membrane potential (ΔΨm). There is considerable variability in IF1 expression and its influence on bioenergetics...
Main Authors: | Helen Tanton, Svetlana Voronina, Anthony Evans, Jane Armstrong, Robert Sutton, David N. Criddle, Lee Haynes, Michael C. Schmid, Fiona Campbell, Eithne Costello, Alexei V. Tepikin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2018.00833/full |
Similar Items
-
Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis
by: Nishikawa, Yoshihiro
Published: (2019) -
Serotonin-RhoA/ROCK axis promotes acinar-to-ductal metaplasia in caerulein-induced chronic pancreatitis
by: Xufeng Tao, et al.
Published: (2020-05-01) -
Ciliogenesis and Hedgehog signalling are suppressed downstream of KRAS during acinar-ductal metaplasia in mouse
by: Fiona K. Bangs, et al.
Published: (2020-07-01) -
Opa1 relies on cristae preservation and ATP synthase to curtail reactive oxygen species accumulation in mitochondria
by: Rubén Quintana-Cabrera, et al.
Published: (2021-05-01) -
A comparison study of pancreatic acinar cell carcinoma with ductal adenocarcinoma using computed tomography in Chinese patients
by: Wang Q, et al.
Published: (2016-09-01)